BioAtla

(NASDAQ) BCAB

Current Price$4.03

Market Cap$6.87M

Since IPO (2020)-100%

5 Year-100%

1 Year-79%

1 Month+5%

BioAtla Financials at a Glance

Market Cap

$6.87M

Revenue (TTM)

$2.00M

Net Income (TTM)

-$50.62M

EPS (TTM)

-$41.83

P/E Ratio

-0.10

Dividend

$0.00

Beta (Volatility)

1.72 (High)

Dividend

$0.00

Beta (Volatility)

1.72 (High)

Price

$4.03

Volume

130

Open

$4.04

Price

$4.03

Volume

130

Open

$4.04

Previous Close

$4.14

Daily Range

$4.03 - $4.04

52-Week Range

$3.12 - $71.50

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

1.72 (High)

Price

$4.03

Volume

130

Open

$4.04

Previous Close

$4.14

Daily Range

$4.03 - $4.04

52-Week Range

$3.12 - $71.50

Estimated Earnings Date

Aug 6, 2026

BCAB News

BioAtla (BCAB) Q2 Loss Narrows 27%

Motley Fool Markets TeamAug 7, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioAtla

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jay M. Short, PhD

Website

www.BioAtla.com

Headquarters

San Diego, CA 92121, US

BCAB Financials

Key Financial Metrics (TTM)

Gross Margin

105.95%

Operating Margin

-2524.95%

Net Income Margin

-2530.85%

Return on Equity

166.67%

Return on Capital

N/A

Return on Assets

-590.91%

Earnings Yield

-10.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.87M

Shares Outstanding

1.66M

Volume

130

Avg. Volume

52.52K

Financials (TTM)

Gross Profit

$2.12M

Operating Income

-$50.50M

EBITDA

-$47.79M

Operating Cash Flow

-$37.18M

Capital Expenditure

$0.00

Free Cash Flow

-$37.18M

Cash & ST Invst.

$1.96M

Total Debt

$6.09M

BioAtla Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$120.00K

+34.4%

Gross Margin

0.00%

N/A

Market Cap

$6.87M

N/A

Market Cap/Employee

$112.63K

N/A

Employees

N/A

Net Income

-$6.34M

+58.6%

EBITDA

-$6.22M

+58.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$1.96M

-93.9%

Total Debt

$6.09M

+1000.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$4.54M

N/A

Short Term Debt

$1.56M

+181.4%

Return on Assets

-5.91%

N/A

Return on Invested Capital

4.16%

N/A

Free Cash Flow

-$5.27M

+67.7%

Operating Cash Flow

-$5.27M

+67.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RVPHReviva Pharmaceuticals Holdings, Inc.

RVPHReviva Pharmaceuticals Holdings, Inc.$0.62-5.28%

CELUCelularity Inc.

CELUCelularity Inc.$0.62+2.86%

EVAXEvaxion Biotech A/S

EVAXEvaxion Biotech A/S$3.06-1.29%

MURAMural Oncology plc

MURAMural Oncology plc$2.04+0.00%

GBIOGeneration Bio Co.

GBIOGeneration Bio Co.$5.34+0.00%

ANVSAnnovis Bio, Inc.

ANVSAnnovis Bio, Inc.$1.91+2.42%

BTAIBioXcel Therapeutics, Inc.

BTAIBioXcel Therapeutics, Inc.$1.38-2.48%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NKENike

NKENike$42.02+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$79.17-0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$37.12+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.60+0.03%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.42+0.04%

NVDANvidia

NVDANvidia$195.67-0.02%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$33.79+0.02%

Questions About BCAB

What is the current price of BioAtla?

BioAtla is trading at $4.03 per share.

What is the 52-week range for BioAtla?

Over the past 52 weeks, BioAtla has traded between $3.12 and $71.50.

How much debt does BioAtla have?

As of the most recent reporting period, BioAtla reported total debt of $6.09M.

How much cash does BioAtla have on hand?

BioAtla reported $1.96M in cash and cash equivalents in its most recent financial results.

What is BioAtla’s dividend yield?

BioAtla does not currently have a dividend yield.

BioAtla

BioAtla Financials at a Glance

BCAB News

BioAtla (BCAB) Q2 Loss Narrows 27%

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About BioAtla

BCAB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

BioAtla Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BCAB

What is the current price of BioAtla?

What is the 52-week range for BioAtla?

How much debt does BioAtla have?

How much cash does BioAtla have on hand?

What is BioAtla’s dividend yield?

Premium Investing Services